Arrowhead Research Corp (NASDAQ:ARWR)
| 2.31 Data as of May 17 |  +0.12 / +5.48%Today’s Change | 1.65 Today|||52-Week Range 5.00 | +7.94% Year-to-Date |
Latest ARWR News | Press Releases
No recent news for Arrowhead Research Corp.
Today’s Trading
| Previous close | 2.19 |
| Today’s open | 2.17 |
| Day’s range | 2.17 - 2.39 |
| Volume | 145,466 |
| Average volume (3 months) | 131,621 |
| Market cap | $72.3M |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/17/2013
Growth & Valuation
| Earnings growth (last year) | -110.89% |
| Earnings growth (this year) | +57.63% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -50.40% |
| P/E ratio | NM |
| Price/Sales | 198.54 |
| Price/Book | 2.84 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| STEMStemCells Inc | +0.06 | +3.21% |
| MAXYMaxygen Inc | +0.02 | +0.85% |
| PBMDPrima BioMed Ltd | -0.43 | -15.47% |
| AEZSAEterna Zentaris Inc | +0.04 | +1.94% |
Data as of 4:00pm ET, 05/17/2013
Financials
| Last reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $146.9K |
| Annual profit (last year) | -$21.1M |
| Net profit margin | -14,383.56% |
Profile
Sector Process Industries |
Industry Industrial Specialties |
President, Chief Executive Officer & Director Christopher R. Anzalone, PhD |
Chief Operating Officer Bruce D. Given, MD |
Corporate headquarters Pasadena, California |
Forecasts
